BIH Johanna Quandt Professorships
Together with the Stiftung Charité and its Private Excellence Initiative Johanna Quandt, the BIH Johanna Quandt Professorships (W2-Professorships with Tenure Track) were established, aimed specifically at women scientists in the fields of translation and systemic medicine. The professorships thus represent a new kind of impulse to promote equal opportunities in the life sciences during the phase of establishing themselves in the scientific system.
BIH Johanna Quandt Professor for Therapy-Induced Remodeling in Immuno-Oncology
On December 1, 2017, Il-Kang Na started the position of BIH Johanna Quandt Professor for Therapy-Induced Remodeling in Immuno-Oncology at BIH and Charité.
BIH Johanna Quandt Professor for Hypertension and the Molecular Biology of Endocrine Tumors
On November 1, 2017, Ute Scholl assumed the position of BIH Johanna Quandt Professor for Hypertension and the Molecular Biology of Endocrine Tumors at BIH and Charité.
BIH Johanna Quandt Professorship for Brain Simulation
On October 1, 2017, Petra Ritter assumed the position of BIH Johanna Quandt Professor for Brain Simulation at BIH and Charité. Read press release here
We interviewed Petra Ritter about her research and future projects:
Three questions to Petra Ritter
What does your research focus on?
The focus of my research is The Virtual Brain (TVB) project, which I have developed in collaboration with various international partners. It is an information platform allowing us to simulate the human brain, as well as the brains of animals such as mice and monkeys. By integrating experimental data in these simulations we can personalize scientific models.
What does the BIH Johanna Quandt Professorship mean for you and your research?
For me this opportunity means a great deal, and in addition to being grateful for the trust bestowed in me, I think that my team and my international partners will benefit greatly from it. I can see effective synergies between BIH and the research I am already conducting, especially in the area of digital health. Currently we are making an application to join the EU flagship project, namely the Human Brain Project. This deals with similar questions being addressed in TVB, since the Human Brain Project will also collect pseudonymized patient data to be used by scientists carrying out research on the human brain.
How will patients benefit from your research in the future?
We are already carrying out research on strokes, brain tumors, Alzheimer’s and epilepsy. The Virtual Brain will allow us to bring together brain structures and functions. This means that we will be able to better-understand and recognize the mechanisms responsible for bringing about these diseases. Once we can understand these relationships, we can make more accurate predictions about the courses of these diseases in addition to applying therapies for them. Our big vision is to use digital doppelgangers as testing grounds for the therapies of the future.